paricalcitol
Selected indexed studies
- Paricalcitol and Extended-Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis. (J Clin Endocrinol Metab, 2023) [PMID:37235771]
- Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis. (Cancer Lett, 2025) [PMID:40409452]
- Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR/CYP2J2 axis. (FASEB J, 2024) [PMID:39441644]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Paricalcitol and Extended-Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis. (2023) pubmed
- Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis. (2025) pubmed
- Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR/CYP2J2 axis. (2024) pubmed
- Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction. (2025) pubmed
- Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis. (2019) pubmed
- Comparison of Paricalcitol and Calcitriol in Dialysis Patients With Secondary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Studies. (2019) pubmed
- Spotlight on paricalcitol in secondary hyperparathyroidism. (2005) pubmed
- Use of Paricalcitol as Adjunctive Therapy to Renin-Angiotensin-Aldosterone System Inhibition for Diabetic Nephropathy: A Systematic Review of the Literature. (2019) pubmed
- Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. (1999) pubmed
- Paricalcitol: a review of its use in the management of secondary hyperparathyroidism. (2005) pubmed